Functional assessment of patients with hypertrophic cardiomyopathy by maximal oxygen consumption;Evaluación funcional de los pacientes con miocardiopatía hipertrófica mediante análisis del consumo de oxígeno máximo

Revista Espanola de Cardiologia

Volumn 56, Issue 9, 2003, Pages 865-872

  de la Morena Valenzuela, Gonzalo ^a   Florenciano Sánchez, Rafael ^a   García Almagro, Francisco J ^a   González Caballero, Eva ^a   Pascual Figal, Domingo ^a   Soria Arcos, Federico ^a   Villegas García, Manuel ^a   Ruipérez Abizanda, Juan A ^a   Valdés Chávarri, Mariano ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Cardiomyopathy; Exercise; Hypertrophy

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; OXYGEN; VERAPAMIL;

ADULT; AEROBIC CAPACITY; ARTICLE; CARDIOPULMONARY HEMODYNAMICS; CLINICAL FEATURE; CLINICAL STUDY; CONTROLLED STUDY; DISEASE CLASSIFICATION; ECHOCARDIOGRAPHY; ERGOMETRY; EXERCISE TEST; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL DISEASE; HEART EJECTION FRACTION; HEART LEFT ATRIUM; HEART SIZE; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE DISEASE; OXYGEN CONSUMPTION; PATHOPHYSIOLOGY; STATISTICAL SIGNIFICANCE;

EID: 0242609226     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051613     Document Type: Article

References (34)

1. Braunwald E. The history. En: Braunwald E, editor. Heart disease. A text-book of cardiovascular medicine. 3th ed. Philadelphia: WB Sanders, 1988; p. 1-12.
2. Candell Riera J, Romero Farina G, Galve Basilio E, Palet Balart J, Armadans L, García del Castillo H, et al. Valor del ecocardiograma-Doppler en el pronóstico y en el seguimiento de la miocardiopatía hipertrófica. Rev Esp Cardiol 2001;54:7-15.
3. Maron BJ, Bonow RO, Cannon RO, Leon MB, Epstein SE. Hypertrophic Cardiomyopathy: interrelations of clinical manifestations, pathophysiology and therapy (two parts). N Engl J Med 1987;336:775-85.
4. Jones S, Elliot PM, Sharma S, McKenna WJ, Whipp BJ. Cardiopulmonary responses to exercise in patients with hypertrophic cardiomyopathy. Heart 1998;80:60-7.
5. Sharma S, Firoozi S, McKenna WJ. Value of exercise testing in assessing clinical state and prognosis in hypertrophic cardiomyopathy. Cardiol Rev 2001;9:70-6.
6. Briguori C, Betocchi S, Romano M, Manganelli F, Losi MA, Ciampi Q, et al. Exercise capacity in hypertrophic cardiomyopathy depends on left ventricular diastolic function. Am J Cardiol 1999;84:309-15.
7. Sharma S, Elliott P, Whyte G, Jones S, Mahon N, Whipp B, et al. Utility of cardiopulmonary exercise in the assessment of clinical determinants of functional capacity in hypertrophic cardiomyopathy. Am J Cardiol 2000;86:162-8.
8. Sharma S, Elliott P, Whyte G, Mahon N, Virdee MS, Mist B, et al. Utility of metabolic exercise in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes. J Am Coll Cardiol 2000;36:864-70.
9. Briguori C, Betocchi S, Manganelli F, Gigante B, Losi MA, Ciampi Q, et al. Determinants and clinical significance of natriuretic peptides in hypertrophic cardiomyopathy. Eur Heart J 2001;22:1328-36.
10. Chikamori T, Counihan PJ, Doi YJ, Takata J, Stewart JT, Frenneaux MP, et al. Mechanisms of exercise limitation in hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;19:507-12.
11. WHO/IFSC. Task Force. Report of the WHO/IFSC task force on the definition and classification of the cardiomyopathies. Circulation 1996;93:841-2.
12. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affect families. Heart 1997;77:130-2.
13. De la Morena G, Ruipérez JA, García García J, Salas J, Jaén E, López Candel J. Miocardiopatía hipertrófica (I). Características clínicas y ecocardiográficas en una población de 72 pacientes. Rev Esp Cardiol 1991;44:11-7.
14. Nishihara K, Mikami T, Takatsuji H, Onozuka H, Saito N, Yamada S, et al. Usefulness of early diastolic flow propagation velocity measured by color M-mode Doppler technique for the assessment of left ventricular diastolic function in patients with hypertrophic cardiomyopathy. J Am Soc Echocardiogr 2000;13: 801-8.
15. Farias CA, Rodríguez L, García MJ, Sun JP, Klein AL, Thomas JD. Assessment of diastolic function by tissue Doppler echocardiography: comparison with standard transmitral and pulmonary venous flow. J Am Soc Echocardiogr 1999;12:609-17.
16. García MJ, Thomas JD, Klein AL. New Doppler echocardiographic applications for the study of diastolic function. J Am Coll Cardiol 1998;32:865-75.
17. Castello R, Labovitz AJ. Evaluation of mitral regurgitation by Doppler echocardiography. Echocardiography 1991;8:699-711.
18. Panza JA, Petrone RK, Fananapazir L, Maron BJ. Utility of continuous wave Doppler echocardiography in the noninvasive assessment of left ventricular outflow tract pressure gradient in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1992;19: 91-9.
19. Bruce RA, Kusumi F, Hosmer D. Maximal oxigen uptake and nomographic assessment of functional aerobic impairment in cardiovascular disease. Am Heart J 1973;85:546-62.
20. Cooper DM, Weiler-Ravel D, Whipp BJ, Wassermann K. Aerobic parameters of exercise as a function of body size during growth in children. J Appl Physiol 1984;56:628-34.
21. Beaver WL, Wassermann K, Whipp BJ. A new method for detecting the anaerobic threshold by gas exchange. J Appl Physiol 1986;60:2020-7.
22. Howley ET, Basset DR, Welch HG. Criteria for maximal oxygen uptake: review and commentary. Med Sci Sports Exerc 1995;27: 1292-301.
23. Cannan CR, Reeder GS, Bailey KR, Melton J, Gersh BJ. Natural history of hypertrophic cardiomyopathy. A population-based study, 1976 through 1990. Circulation 1995;92:2488-95.
24. Wigle ED, Rakowski H, Kimball BP, Williams WG. Hypertrophic cardiomyopathy. Clinical spectrum and treatment. Circulation 1995;92:1680-92.
25. Maron BJ, Casey SA, Poliac LC, Gohman T, Alquist AK, Aeppli DM. Clinical course of hypertrophic cardiomyopathy in a regional United States cohort. JAMA 1999;281:650-5.
26. Wasserman K, Van Kessel AL, Burton GG. Interaction of physiologycal mechanisms during exercise. J Appl Physiol 1967;22:71-85.
27. Cannon RO, Rosing DR, Maron BJ. Myocardial ischemia in hypertrophic cardiomyopathy: contribution of inadequate vasodilatador reserve and elevated left ventricular filling pressures. Circulation 1985;71:234-43.
28. Maron BJ, Wolfson JK, Epstein SE, Roberts WC. Intramural (small vessel) coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8:545-57.
29. Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation 1995;92:2886-94.
30. Spirito P, Maron BJ, Bonow RO, Epstein SE. Occurrence and significance of progresive left ventricular wall thinning and relative cavity dilatation in patients with hypertrophic cardiomyopathy. Am J Cardiol 1987;60:123-9.
31. Nihoyannopoulos P, Haratasakis G, Frenneaux MP, McKenna WJ, Oakley CM. Diastolic function in hypertrophic cardiomyopathy: relation to exercise capacity. J Am Coll Cardiol 1992;19:536-40.
32. Nishimura R, Appleton CP, Redfield MM, Ilstrup DM, Holmes DR, Tajik AJ. Noninvasive Doppler echocardiographic evaluation of left ventricular filling pressure in patients with cardiomyopathy: a simultaneous Doppler echocardiographic and cardiac catheterization study. J Am Coll Cardiol 1996;28:1226-33.
33. Counihan PJ, Frenneaux MP, Webb DJ, McKenna WJ. Abnormal vascular responses to supine exercise in hypertrophic cardiomyopathy. Circulation 1991;84:686-96.
34. Cuda G, Fananapazir L, Zhu W-S, Sellers J, Epstein ND. Skeletal muscle expression and abnormal function of β myosin in hypertrophic cardiomyopathy. J Clin Invest 1993;91:2861-5.